Monika Sztankay

Barbara Sperner-Unterweger2
Verena Meraner2
Petra Wiesbauer1
2Barbara Sperner-Unterweger
2Verena Meraner
1Petra Wiesbauer
Learn More
Diagnosis and treatment of ovarian cancer (OC) entail severe symptom burden and a significant loss of quality of life (QOL). Somatic and psychological impairments may persist well beyond active therapy. Although essential for optimal symptom management as well as for the interpretation of treatment outcomes, knowledge on the course of QOL-related issues is(More)
Current studies on adherence to endocrine therapy in breast cancer patients suffer from methodological limitations due to a lack of well-validated methods for assessing adherence. There is no gold standard for measuring adherence. The aim of our study was to compare four different approaches for evaluating adherence to anastrozole therapy for breast cancer(More)
  • 1